George Church and company have cooked up a scheme for harnessing components of the bacterial "clustered interspersed short palindromic repeat" and "CRISPR-associated" system — normally used in adaptive immunity — to aid in genome engineering efforts using the budding yeast Saccharomyces cerevisiae. As they report in the online edition of Nucleic Acids Research, the researchers relied on RNA-guided endonuclease activity offered by components from the type II CRISPR-Cas system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Cell

Be Gone

This Week in Science

This Week in Cell

This Week in Nature

This Week in Nature

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.